Skip to main content

Prevalence of Diabetes 15.8 Percent in U.S. Adults From 2021 to 2023

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 7, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Nov. 6, 2024 -- The prevalence of diabetes was 15.8 percent among U.S. adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Jane A. Gwira, M.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the National Health and Nutrition Examination Survey to examine the prevalence of diagnosed, undiagnosed, and total diabetes (excluding gestational diabetes) among U.S. adults during August 2021 to August 2023.

The researchers found that the prevalence of total diabetes was 15.8 percent, and the prevalence rates of diagnosed and undiagnosed diabetes were 11.3 and 4.5 percent, respectively, among U.S. adults during August 2021 to August 2023. Men had a higher prevalence of total and diagnosed diabetes than women (18.0 and 12.9 percent versus 13.7 and 9.7 percent). With age and with increasing weight status, there was an increase in the prevalence of total, diagnosed, and undiagnosed diabetes. Between 1999-2002 and August 2021 to August 2023, there was an increase in the age-adjusted prevalence of total and diagnosed diabetes.

"Slightly more than one-quarter of adults with diabetes had undiagnosed diabetes," the authors write. "Continued monitoring of both diagnosed and undiagnosed diabetes will provide essential information about the prevalence of diabetes in adults in the United States."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

Increasing Proportion of U.S. Adults Unaware They Have Hypertension

MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...

Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM

MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...

Concurrent Hypertension + Type 2 Diabetes Predict High Mortality Risk

WEDNESDAY, June 4, 2025 -- Adults with concurrent hypertension and type 2 diabetes (T2D) have high mortality risk compared with those who have neither condition or only one...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.